Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS alumnus Dr Anand Segar has been awarded the Louis Barnett Prize 2015, presented to a young New Zealand surgeon or surgical trainee with the best research paper at the Royal Australasian College of Surgeons New Zealand Annual Meeting.

Anand Segar (left) with the Chair of the NZ ASM Organising Committee, Nigel Willis.
Anand Segar (left) with the Chair of the NZ ASM Organising Committee, Nigel Willis.

Anand is currently an Orthopaedic Surgery Trainee in Hamilton, New Zealand. He interrupted his orthopaedic training to pursue full time research in Oxford and completed his DPhil at NDORMS this year.

Speaking of this prize, he says: "Previous award recipients are now eminent surgeons and leaders within their field. Winning this award is an inspiration to continue along an academic surgical pathway. The competition was tough with excellent papers so I was very surprised but hugely excited to receive the Louis Barnett Prize for my in vitro research."

Anand also received a European Spine Society Award in the second year of his DPhil and the Osteoarthritis Research Society International (OARSI) Young Investigators Award earlier this year for his epidemiological research.

“These awards are a nice recognition for hard work. I am tremendously grateful to my supervisors and mentors Dr Jill Urban, Associate Professor Andy Judge and Professor Jeremy Fairbank who supported and encouraged me throughout my DPhil”, says Anand.

"NDORMS is a motivating and inspirational environment for orthopaedic research. The resources and expertise available are amazing. My DPhil was unique in the sense that it was translation with in vitro, clinical and epidemical aspects. As a young surgeon, this was an ideal fit and almost only possible at NDORMS. There are few places in the world where you can immerse yourself in such an environment.”

"I must also thank my funders, the Royal Australasian College of Surgeons Foundation for Surgery, the Commonwealth Scholarships Commission, the Oxford Nuffield Medical Trust and the New Zealand Orthopaedic Association Wishbone Trust."

 

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.